Stephen Taplin, MD, MPH, is the Deputy Associate Director of the Healthcare Delivery Research Program. He is an internationally recognized expert in the field of cancer screening. He completed his Family Medicine Residency in Rochester, New York, in 1983, and his Robert Wood Johnson Fellowship in Seattle in 1985.
Dr. Taplin built his research career around the problems that arose from his day-to-day practice as a primary care physician and the leader of a breast cancer screening program that served 100,000 women in an integrated health plan. He has been conducting research funded by the National Cancer Institute for most of his career, and he has more than 150 publications in peer-reviewed journals, including work on determinants of mammography use, factors affecting mammography interpretation, costs of cancer care, and the evaluation of screening implementation.
Dr. Taplin moved to the NCI in September 2003 after becoming a Senior Investigator at the Center for Health Studies and Professor in the Department of Family Medicine at the University of Washington. His responsibilities as the Deputy Associate Director include overseeing research on cancer screening implementation and the development of the scientific core of HDRP, where he continues to consider the link between the processes and outcomes of care, teams in healthcare delivery, and cancer screening.
Last Updated: 21 May 2015